• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[喜树碱-纺锤菌素杂合分子内酯-羧酸盐转变的动力学]

[Kinetics of the lactone-carboxylate transition of hybrid camptothecin-netropsin molecules].

作者信息

Oleĭnikov V A, Ustinova O A, Mochalov K E, Ermishov M A, Grokhovskiĭ S L, Zhuze A L, Sukhanova A V, Nabiev I R

机构信息

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, ul. Miklukho-Maklaya 16/10, Moscow, 117997 Russia.

出版信息

Biofizika. 2003 May-Jun;48(3):436-42.

PMID:12815854
Abstract

The kinetics of the hydrolysis of the lactone ring of a hybrid molecule containing the molecules of the antitumor drug camptothecin and a derivative of the antibiotic netropsines, which is highly affine and specific to the DNA A-T sequences was investigated. It was shown that intramolecular interaction significantly slows down the rate of hydrolysis but does not change the equilibrium ratio of concentrations of the lactone and carboxylate forms of the camptothecin fragment of the hybrid molecule, which corresponds to the pH value. The use of intramolecular interaction for controlling the kinetics of the lactone/carboxylate transition makes it possible to create the drugs of the camptothecin family, which preserve the biologically active lactone form under the physiological conditions for a longer time and, therefore, are more effective as anticancer agents.

摘要

研究了一种杂合分子内酯环的水解动力学,该杂合分子包含抗肿瘤药物喜树碱分子和抗生素纺锤菌素的衍生物,后者对DNA的A-T序列具有高度亲和力和特异性。结果表明,分子内相互作用显著减慢了水解速率,但并未改变杂合分子中喜树碱片段内酯形式和羧酸盐形式浓度的平衡比,该平衡比与pH值相对应。利用分子内相互作用来控制内酯/羧酸盐转变的动力学,使得制备喜树碱家族药物成为可能,这类药物在生理条件下能更长时间地保持生物活性内酯形式,因此作为抗癌剂更有效。

相似文献

1
[Kinetics of the lactone-carboxylate transition of hybrid camptothecin-netropsin molecules].[喜树碱-纺锤菌素杂合分子内酯-羧酸盐转变的动力学]
Biofizika. 2003 May-Jun;48(3):436-42.
2
Kinetic and thermodynamic studies of 9-aminocamptothecin hydrolysis at physiological pH in the presence of human serum albumin.在生理 pH 值和人血清白蛋白存在的条件下,对 9-氨基喜树碱水解的动力学和热力学研究。
Eur J Pharm Sci. 2013 Aug 16;49(5):858-63. doi: 10.1016/j.ejps.2013.06.005. Epub 2013 Jun 19.
3
Camptothecin conjugated with DNA minor-groove binder netropsin: enhanced lactone stability, inhibition of human DNA topoisomerase I and antiproliferative activity.与DNA小沟结合剂纺锤菌素缀合的喜树碱:内酯稳定性增强、对人DNA拓扑异构酶I的抑制作用及抗增殖活性。
Anticancer Res. 2003 May-Jun;23(3B):2609-15.
4
Differential interactions of camptothecin lactone and carboxylate forms with human blood components.喜树碱内酯和羧酸盐形式与人血液成分的差异相互作用。
Biochemistry. 1994 Aug 30;33(34):10325-36. doi: 10.1021/bi00200a013.
5
Stabilization of the Karenitecin® lactone by alpha-1 acid glycoprotein.通过α-1酸性糖蛋白对卡瑞奈辛内酯进行稳定化处理。
Cancer Chemother Pharmacol. 2015 Apr;75(4):719-28. doi: 10.1007/s00280-015-2686-y. Epub 2015 Jan 30.
6
Urinary and biliary disposition of the lactone and carboxylate forms of 20(S)-camptothecin in rats.
Drug Metab Dispos. 1994 May-Jun;22(3):438-42.
7
Kinetics of lactone hydrolysis in antitumor drugs of camptothecin series as studied by fluorescence spectroscopy.通过荧光光谱法研究喜树碱系列抗肿瘤药物中内酯水解的动力学
Biochim Biophys Acta. 1998 Mar 2;1379(3):353-66. doi: 10.1016/s0304-4165(97)00115-3.
8
Camptothecin and thiocamptothecin: the role of sulfur in shifting the hydrolysis equilibrium towards the closed lactone form.喜树碱和硫代喜树碱:硫在平衡移动中对形成闭环内酯形式的作用。
ChemMedChem. 2011 Sep 5;6(9):1706-14. doi: 10.1002/cmdc.201100206. Epub 2011 Jun 22.
9
The structural basis of camptothecin interactions with human serum albumin: impact on drug stability.喜树碱与人血清白蛋白相互作用的结构基础:对药物稳定性的影响。
J Med Chem. 1994 Jan 7;37(1):40-6. doi: 10.1021/jm00027a005.
10
Effect of injection routes on pharmacokinetics and lactone/carboxylate equilibrium of 9-Nitrocamptothecin in rats.注射途径对大鼠9-硝基喜树碱药代动力学及内酯/羧酸盐平衡的影响。
Int J Pharm. 2007 Aug 1;340(1-2):29-33. doi: 10.1016/j.ijpharm.2007.03.008. Epub 2007 Mar 12.